| Ident. | Authors (with country if any) | Title |
|---|
| 000007 (2021) |
Natalia Sasoni [Argentine] ; Milton Rodriguez Müller [Argentine] ; Graciela Posse [Argentine] ; Jorge González [Argentine] ; Florencia Leonardelli [Argentine] ; Guillermo Garcia-Effron [Argentine] | SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids. |
| 000037 (2021) |
Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne] | What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects. |
| 000038 (2021) |
María Antonela Zígolo [Argentine] ; Matías Rivero Goytia [Argentine] ; Hugo Ramiro Poma [Argentine] ; Ver Nica Beatriz Rajal [Singapour] ; Ver Nica Patricia Irazusta [Argentine] | Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools. |
| 000039 (2021) |
Roland Duculan ; Deanna Jannat-Khah ; Bella Mehta ; Lisa A. Mandl ; Medha Barbhaiya ; Anne R. Bass ; Carol A. Mancuso | Variables Associated With Perceived Risk of Contracting SARS-CoV-2 Infection During the COVID-19 Pandemic Among Patients With Systemic Rheumatic Diseases. |
| 000052 (2021) |
Santanu Santra [Inde] ; Santanab Giri [Inde] ; Madhurima Jana [Inde] | Unraveling the origin of interactions of hydroxychloroquine with the receptor-binding domain of SARS-CoV-2 in aqueous medium. |
| 000055 (2021) |
Tuan V. Nguyen [Australie] | Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load. |
| 000058 (2021) |
George N. Ioannou [États-Unis] ; Ann M. O'Hare [États-Unis] ; Kristin Berry [États-Unis] ; Vincent S. Fan [États-Unis] ; Kristina Crothers [États-Unis] ; Mckenna C. Eastment [États-Unis] ; Emily Locke [États-Unis] ; Pamela Green [États-Unis] ; Javeed A. Shah [États-Unis] ; Jason A. Dominitz [États-Unis] | Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection. |
| 000069 (2021) |
Waqas Aslam [Oman] ; Carla R. Lamb [États-Unis] ; Nadia Ali [États-Unis] | Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications. |
| 000072 (2021) |
Konstantinos Parperis [Chypre (pays), États-Unis] | To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic. |
| 000075 (2021) |
Sawsan Elgohary [Égypte] ; Aya A. Elkhodiry [Égypte] ; Nada S. Amin [Égypte] ; Ulrike Stein [Allemagne] ; Hend M. El Tayebi [Égypte] | Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? |
| 000086 (2021) |
Gerard Espinosa [Espagne] ; Sergio Prieto-González [Espagne] ; Mireia Llevadot [Espagne] ; Javier Marco-Hernández [Espagne] ; Antonio Martínez-Artu A [Espagne] ; Albert Pérez-Isidro [Espagne] ; Elia Rifé [Espagne] ; Ricard Cervera [Espagne] | The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia. |
| 000094 (2021) |
Subham Das [Inde] ; Anu Kunnath Ramachandran [Inde] ; Sumit Raosaheb Birangal [Inde] ; Saleem Akbar [Inde] ; Bahar Ahmed [Inde] ; Alex Joseph [Inde] | The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review. |
| 000098 (2021) |
Antonio Desai [Italie] ; Giuseppe Caltagirone [Italie] ; Sharon Sari [Italie] ; Daria Pocaterra [Italie] ; Maria Kogan [Italie] ; Elena Azzolini [Italie] ; Victor Savevski [Italie] ; Filippo Martinelli-Boneschi [Italie] ; Antonio Voza [Italie] ; On Behalf Of The Humanitas Covid-Task Force [Italie] | The Use of Antiviral Agents against SARS-CoV-2: Ineffective or Time and Age Dependent Result? A Retrospective, Observational Study among COVID-19 Older Adults. |
| 000110 (2021) |
Consolato M. Sergi [Canada] ; Brian Chiu [Canada] | Targeting NLRP3 inflammasome in an animal model for Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). |
| 000114 (2021) |
Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis] | Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection. |
| 000116 (2021) |
Sathishkumar Chidambaram [Inde] ; Mohamed A. El-Sheikh [Arabie saoudite] ; Ahmed H. Alfarhan [Arabie saoudite] ; Surendrakumar Radhakrishnan [Inde] ; Idhayadhulla Akbar [Inde] | Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies. |
| 000117 (2021) |
Tesia Bobrowski [États-Unis] ; Lu Chen [États-Unis] ; Richard T. Eastman [États-Unis] ; Zina Itkin [États-Unis] ; Paul Shinn [États-Unis] ; Catherine Z. Chen [États-Unis] ; Hui Guo [États-Unis] ; Wei Zheng [États-Unis] ; Sam Michael [États-Unis] ; Anton Simeonov [États-Unis] ; Matthew D. Hall [États-Unis] ; Alexey V. Zakharov [États-Unis] ; Eugene N. Muratov [États-Unis] | Synergistic and Antagonistic Drug Combinations against SARS-CoV-2. |
| 000120 (2021) |
Giancarlo Ceccarelli [Italie] ; Francesco Alessandri [Italie] ; Alessandra Oliva [Italie] ; Serena Dell'Isola [Italie] ; Monica Rocco [Italie] ; Franco Ruberto [Italie] ; Francesco Pugliese [Italie] ; Gabriella D'Ettorre [Italie] ; Mario Venditti [Italie] | Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. |
| 000121 (2021) |
| Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection. |
| 000127 (2021) |
Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar] | Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2. |
| 000128 (2021) |
Deepak Mishra [Inde] ; Radha Raman Maurya [Inde] ; Kamlesh Kumar [Inde] ; Nupur S. Munjal [Inde] ; Vijay Bahadur [Inde] ; Sandeep Sharma [Inde] ; Prashant Singh [Inde] ; Indra Bahadur [Afrique du Sud] | Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. |
| 000129 (2021) |
Sinosh Skariyachan [Inde] ; Dharshini Gopal [Inde] ; Aditi G. Muddebihalkar [Inde] ; Akshay Uttarkar [Inde] ; Vidya Niranjan [Inde] | Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies. |
| 000130 (2021) |
Yudibeth Sixto-L Pez [Mexique] ; José Correa-Basurto [Mexique] ; Martiniano Bello [Mexique] ; Bruno Landeros-Rivera [France] ; Jose Antonio Garz N-Tiznado [Mexique] ; Sarita Monta O [Mexique] | Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population. |
| 000146 (2021) |
Rahul Sharma [Inde] ; Dharmendra Khokhar [Inde] ; Bhanushree Gupta [Inde] ; Purnendu Saxena [Inde] ; Kallol Kumar Ghosh [Inde] ; Arvind Kumar Geda [Inde] ; Kamil Kuca | Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics. |
| 000155 (2021) |
Alberto Enrico Maraolo [Italie] ; Adriano Grossi [Italie] | Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials. |
| 000159 (2021) |
Masoud Solaymani-Dodaran [Iran] ; Mostafa Ghanei [Iran] ; Mehdi Bagheri [Iran] ; Ali Qazvini [Iran] ; Ensieh Vahedi [Iran] ; Seyed Hassan Saadat [Iran] ; Seyed Amin Setarehdan [Iran] ; Akram Ansarifar [Iran] ; Hossein Biganeh [Iran] ; Arash Mohazzab [Iran] ; Davood Khalili [Iran] ; Amir Hosein Ghazale [Iran] ; Mohammad Reza Heidari [Iran] ; Ali Taheri [Iran] ; Maliheh Khoramdad [Iran] ; Mohammad Mahdi Asadi [Iran] ; Masoud Nazemieh [Iran] ; Mojtaba Varshochi [Iran] ; Samaneh Abbasian [Iran] ; Ali Bakhtiari [Iran] ; Reza Mosaed [Iran] ; Seyyed-Javad Hosseini-Shokouh [Iran] ; Masoume Shahrokhi [Iran] ; Zeynab Yassin [Iran] ; Mohammad Ali Zohal [Iran] ; Maryam Qaraati [Iran] ; Nafiseh Rastgoo [Iran] ; Ramin Sami [Iran] ; Mohammad Javad Eslami [Iran] ; Akram Asghari [Iran] ; Mansoor Namazi [Iran] ; Shadi Ziaie [Iran] ; Raana Jafari-Moghaddam [Iran] ; Saeid Kalantari [Iran] ; Mohammad Memarian [Iran] ; Javad Khodadadi [Iran] ; Mohammad Hossein Afshari [Iran] ; Mansooreh Momen-Heravi [Iran] ; Niusha Behzadseresht [Iran] ; Ahmad Reza Mobayen [Iran] ; Abolfazl Mozafari [Iran] ; Fatemeh Movasaghi [Iran] ; Maryam Haddadzadeh Shoushtari [Iran] ; Javad Moazen [Iran] | Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. |
| 000163 (2021) |
Tanvir Rahman [États-Unis] ; Quazim A. Alayo [États-Unis] ; Sibgha G. Chaudhary [États-Unis] ; Reihaneh C. Moghadam [États-Unis] ; Matthew L. German [États-Unis] ; Neil A. Ettinger [États-Unis] ; Jeremy E. Leidenfrost [États-Unis] ; Hope A. Cranston-D'Amato [États-Unis] ; Morton R. Rinder [États-Unis] ; Julianne E. Donnelly [États-Unis] | STEMI associated with SARS-CoV-2 infection and the use of ECMO as a potential therapeutic approach in addition to the PCI. |
| 000167 (2021) |
Masoomeh Sofian [Iran] ; Ali Akbar Velayati [Iran] ; Mohammad Banifazl [Iran] ; Fatemeh Fotouhi [Iran] ; Mona Sadat Larijani [Iran] ; Neda Afzali [Iran] ; Amitis Ramezani [Iran] | SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms. |
| 000168 (2021) |
Peyman Kheirandish Zarandi [Iran] ; Mohammad Reza Zinatizadeh [Iran] ; Maryam Zinatizadeh [Iran] ; Mohammad Hadi Yousefi [Iran] ; Nima Rezaei [Iran] | SARS-CoV-2: From the pathogenesis to potential anti-viral treatments. |
| 000169 (2021) |
Bianca D. Balmant [Brésil] ; Raquel S. Torrinhas [Brésil] ; Ilanna M. Rocha [Brésil] ; Danielle C. Fonseca [Brésil] ; Francisco F C. Formiga [Brésil] ; Eloisa S D O. Bonfá [Brésil] ; Eduardo F. Borba [Brésil] ; Dan L. Waitzberg [Brésil] | SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link? |
| 000170 (2021) |
Filipa Silva [Portugal] ; Ana Cipriano [Portugal] ; Hugo Cruz [Portugal] ; Joana Tavares [Portugal] ; Joana Fragoso [Portugal] ; Jorge Malheiro [Portugal] ; Manuela Almeida [Portugal] ; La Salete Martins [Portugal] ; Miguel Abreu [Portugal] ; Sofia Pedroso [Portugal] ; Leonídio Dias [Portugal] ; Ant Nio Castro Henriques [Portugal] | SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases. |
| 000171 (2021) |
Carmen Manciuc [Roumanie] ; Dragos Nemescu [Roumanie] ; Andrei Vata [Roumanie] ; Georgiana Alexandra Lacatusu [Roumanie] | SARS-CoV-2 infection and diabetes mellitus: A North Eastern Romanian experience. |
| 000172 (2021) |
Fanny Onodi [France] ; Lucie Bonnet-Madin [France] ; Laurent Meertens [France] ; Léa Karpf [France] ; Justine Poirot [France] ; Shen-Ying Zhang [France, États-Unis] ; Capucine Picard [France] ; Anne Puel [France, États-Unis] ; Emmanuelle Jouanguy [France, États-Unis] ; Qian Zhang [États-Unis] ; Jérôme Le Goff [France] ; Jean-Michel Molina [France] ; Constance Delaugerre [France] ; Jean-Laurent Casanova [France, États-Unis] ; Ali Amara [France] ; Vassili Soumelis [France] | SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. |
| 000173 (2021) |
Fanny Onodi [France] ; Lucie Bonnet-Madin [France] ; Laurent Meertens [France] ; Léa Karpf [France] ; Justine Poirot [France] ; Shen-Ying Zhang [États-Unis] ; Capucine Picard ; Anne Puel [États-Unis] ; Emmanuelle Jouanguy [États-Unis] ; Qian Zhang [États-Unis] ; Jérôme Le Goff [France] ; Jean-Michel Molina [France] ; Constance Delaugerre [France] ; Jean-Laurent Casanova [États-Unis] ; Ali Amara [France] ; Vassili Soumelis [France] | SARS-CoV-2 induces human plasmacytoid pre-dendritic cell diversification via UNC93B and IRAK4. |
| 000174 (2021) |
Abdo A. Elfiky [Égypte] | SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. |
| 000175 (2021) |
Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen Sliwa | SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications. |
| 000176 (2021) |
Hareesh Krishnan [Inde] ; M. Leema [Inde] ; G S Gopika [Inde] ; P M Hari Prasad [Inde] ; Abhilash Rajan [Inde] ; Arathy Anil [Inde] ; Anandhu P. Dev [Inde] ; Zeena S. Pillai [Inde] | SARS CoV-2: Progression and Treatment Protocols- An Overview. |
| 000177 (2021) |
Kevin L. Winthrop [États-Unis] ; Amanda E. Brunton [États-Unis] ; Susan Beekmann [États-Unis] ; Philip Polgreen [États-Unis] ; John Baddley [États-Unis] ; Kenneth G. Saag [États-Unis] ; Cassandra Calabrese [États-Unis] ; Leonard Calabrese [États-Unis] ; Philip C. Robinson [Australie] ; Zachary S. Wallace [États-Unis] ; Jeffrey R. Curtis [États-Unis] | SARS CoV-2 infection among patients using immunomodulatory therapies. |
| 000179 (2021) |
Priyamadhaba Behera [Inde] ; Binod Kumar Patro [Inde] ; Arvind Kumar Singh [Inde] ; Pradnya Dilip Chandanshive [Inde] ; Ravikumar S R [Inde] ; Somen Kumar Pradhan [Inde] ; Siva Santosh Kumar Pentapati [Inde] ; Gitanjali Batmanabane [Inde] ; Prasanta Raghab Mohapatra [Inde] ; Biswa Mohan Padhy [Inde] ; Shakti Kumar Bal [Inde] ; Sudipta Ranjan Singh [Inde] ; Rashmi Ranjan Mohanty [Inde] | Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study. |
| 000193 (2021) |
Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Hervé Chaudet [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. |
| 000197 (2021) |
Paolo Agostinis [Italie] ; Valentina Vianello [Italie] ; Elena Dereani [Italie] ; Giuseppe Caruso [Italie] ; Beatrice Montessoro [Italie] ; Marco Taurian [Italie] ; Antonio Di Chiara [Italie] ; Vincenzo Patruno [Italie] ; Francesco Cavallin [Italie] ; Gian Paolo Fadini [Italie] ; Anna Aldovini [États-Unis] ; Anna Baritussio [Italie] ; Francesco Curcio [Italie] ; Carlo Tascini [Italie] ; Aldo Baritussio [Italie] | Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center. |
| 000198 (2021) |
Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie] | Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis. |
| 000199 (2021) |
Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie] | Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al. |
| 000203 (2021) |
F O Shode [Afrique du Sud] ; A S K. Idowu [Afrique du Sud] ; O J Uhomoibhi [Afrique du Sud] ; S. Sabiu [Afrique du Sud] | Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2. |
| 000221 (2021) |
Seongman Bae [Corée du Sud] ; Byeongzu Ghang [Corée du Sud] ; Ye-Jee Kim [Corée du Sud] ; Joon Seo Lim [Corée du Sud] ; Sung-Cheol Yun [Corée du Sud] ; Yong-Gil Kim [Corée du Sud] ; Sang-Oh Lee [Corée du Sud] ; Sung-Han Kim [Corée du Sud] | Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea. |
| 000232 (2021) |
Maximilian Gro E [Allemagne] ; Natalia Ruetalo [Allemagne] ; Mirjam Layer [Allemagne] ; Dan Hu [Allemagne] ; Ramona Businger [Allemagne] ; Sascha Rheber [Allemagne] ; Christian Setz [Allemagne] ; Pia Rauch [Allemagne] ; Janina Auth [Allemagne] ; Maria Fröba [Allemagne] ; Ekkehard Brysch [Allemagne] ; Michael Schindler [Allemagne] ; Ulrich Schubert [Allemagne] | Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2. |
| 000241 (2021) |
Walter Filgueira De Azevedo Junior ; Gabriela Bitencourt-Ferreira ; Joana Retzke Godoy ; Hilda Mayela Aran Adriano ; Wallyson André Dos Santos Bezerra [États-Unis] ; Alexandra Martins Dos Santos Soares [États-Unis] | Protein-ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2. |
| 000246 (2021) |
Jacobo Rogado [Espagne] ; Pedro Gull N [Espagne] ; Berta Obispo [Espagne] ; Gloria Serrano [Espagne] ; Miguel Lara [Espagne] | Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors. |
| 000251 (2021) |
Tali Eviatar [Israël] ; Ofir Elalouf [Israël] ; Victoria Furer [Israël] ; Yael Goldstein-Lahat [Israël] ; Yael Paran [Israël] ; Sara Pel [Israël] ; Sharon Nevo [Israël] ; Michael Zisapel [Israël] ; Yifat Alcalay [Israël] ; Ori Elkayam [Israël] | Prevalence of COVID-19 and seroprevalence to SARS-CoV-2 in a rheumatologic patient population from a tertiary referral clinic in Israel. |
| 000257 (2021) |
Daniel Sammartino [États-Unis] ; Farrukh Jafri [États-Unis] ; Brennan Cook [États-Unis] ; Lisa La [États-Unis] ; Hyemin Kim [États-Unis] ; John Cardasis [États-Unis] ; Joshua Raff [États-Unis] | Predictors for inpatient mortality during the first wave of the SARS-CoV-2 pandemic: A retrospective analysis. |
| 000262 (2021) |
Doaa A. Ghareeb [Égypte] ; Samar R. Saleh [Égypte] ; Mohammed S. Nofal ; Mohamed M Y. Kaddah ; Salma F. Hassan ; Inas K. Seif [Égypte] ; Sally A. El-Zahaby [Égypte] ; Shaimaa M. Khedr ; Marwa Y. Kenawy ; Aliaa A. Masoud [Égypte] ; Salma A. Soudi ; Ahmed A. Sobhy [Égypte] ; Jaillan G. Sery ; Miral G Abd El-Wahab ; Alshimaa A Abd Elmoneam [Égypte] ; Abdulaziz Mohsen Al-Mahallawi [Égypte] ; Maha A. El-Demellawy | Potential therapeutic and pharmacological strategies for SARS-CoV2. |
